image
Catalent, Inc. CTLT
Healthcare - Drug Manufacturers - Specialty & Generic - NYSE - US
Watchlist
$ 59.1
0.323 %
$ 10.7 B
Market Cap
-25.92
P/E
FINANCIAL REPORTS

Reports

Report Date Revenue YoY Net Income YoY Operating Income YoY View
Annual Report FY 10-K 2024-06-30 2.46% -349.57% 205.84%
Annual Report FY 10-K 2023-06-30 -11.43% -46.49% -39.26%
Annual Report FY 10-K 2022-06-30 20.76% -14.70% -1.41%
Annual Report FY 10-K 2021-06-30 29.21% 238.15% 146.18%
Annual Report FY 10-K 2020-06-30 22.89% 25.91% 132.69%
Annual Report FY 10-K 2019-06-30 2.22% 64.35% -77.20%
Annual Report FY 10-K 2018-06-30 18.70% -23.86% 15.76%
Annual Report FY 10-K 2017-06-30 12.30% -1.52% 7.53%
Annual Report FY 10-K 2016-06-30 0.94% -47.46% -16.20%
Annual Report FY 10-K 2015-06-30 0.17% 1209.88% 7.89%
Annual Report FY 10-K 2014-06-30 1.52% 134.69% 17.86%
Annual Report FY 10-K 2013-06-30 6.22% -91.39% 3.23%
Annual Report FY 10-K 2012-06-30 10.64% 54.81% 6.39%
Annual Report FY 10-K 2011-06-30 0.00% 0.00% 0.00%
Quarterly Report Q1 8-K 2024-09-30 4.18% 81.96% 90.34%
Quarterly Report Q4 8-K 2024-06-30 21.82% 126.74% 260.00%
Quarterly Report Q3 8-K 2024-03-31 3.57% 55.51% 32.00%
Quarterly Report Q2 8-K 2023-12-31 -10.88% -254.32% -11.59%
Quarterly Report Q1 8-K 2023-09-30 -3.91% 0.00% -1225.00%
Quarterly Report Q4 8-K 2023-06-30 -18.66% -45.99% -40.65%
Quarterly Report Q3 8-K 2023-03-31 -18.54% -160.99% -11.85%
Quarterly Report Q2 8-K 2022-12-31 -5.59% -12.90% -14.29%
Quarterly Report Q1 8-K 2022-09-30 -0.29% 0.00% -56.52%
Quarterly Report Q4 8-K 2022-06-30 10.52% 10.72% -1.99%
Quarterly Report Q3 8-K 2022-03-31 20.86% -35.02% -42.76%
Quarterly Report Q2 8-K 2021-12-31 33.62% 20.78% 27.17%
Quarterly Report Q1 8-K 2021-09-30 21.20% 21.74% 69.33%
Quarterly Report Q4 8-K 2021-06-30 25.37% 25.76% 47.47%
Quarterly Report Q3 8-K 2021-03-31 38.48% 938.28% 265.67%
Quarterly Report Q2 8-K 2020-12-31 26.25% 124.49% 42.25%
Quarterly Report Q1 8-K 2020-09-30 27.23% 68900.00% 136.92%
Quarterly Report Q4 8-K 2020-06-30 30.58% 104.41% 55.43%
Quarterly Report Q3 8-K 2020-03-31 23.17% -34.07% 53.19%
Quarterly Report Q2 8-K 2019-12-31 15.79% -30.00% 13.81%
Quarterly Report Q1 8-K 2019-09-30 20.46% 100.69% 68.63%
Quarterly Report Q4 8-K 2019-06-30 5.90% -20.56% 12.54%
Quarterly Report Q3 8-K 2019-03-31 -1.66% 66.84% -9.99%
Quarterly Report Q2 8-K 2018-12-31 2.75% 323.74% 13.66%
Quarterly Report Q1 8-K 2018-09-30 1.45% -378.95% -36.05%
Quarterly Report Q4 8-K 2018-06-30 11.09% 33.82% 0.41%
Quarterly Report Q3 8-K 2018-03-31 17.89% -26.92% 13.16%
Quarterly Report Q2 8-K 2017-12-31 25.35% -125.86% 43.63%
Quarterly Report Q1 8-K 2017-09-30 23.00% -17.39% 28.63%
Quarterly Report Q4 8-K 2017-06-30 15.92% -0.16% 6.72%
Quarterly Report Q3 8-K 2017-03-31 21.60% 142.99% 105.08%
Quarterly Report Q2 8-K 2016-12-31 6.33% -43.32% -18.26%
Quarterly Report Q1 8-K 2016-09-30 4.54% -49.45% -33.15%
Quarterly Report Q4 8-K 2016-06-30 4.33% -59.73% 1.79%
Quarterly Report Q3 8-K 2016-03-31 -1.93% -66.03% -52.13%
Quarterly Report Q2 8-K 2015-12-31 -0.20% -33.98% -6.09%
Quarterly Report Q1 8-K 2015-09-30 1.12% 146.67% -12.71%
Quarterly Report Q4 8-K 2015-06-30 -1.83% 465.07% -11.77%
Quarterly Report Q3 8-K 2015-03-31 -1.43% 370.15% 9.30%
Quarterly Report Q2 8-K 2014-12-31 3.43% 342.19% 40.22%
Quarterly Report Q1 8-K 2014-09-30 0.97% -1300.00% 21.08%
Quarterly Report Q4 8-K 2014-06-30 2.85% 41.67% 28.79%
Quarterly Report Q3 8-K 2014-03-31 1.36% 135.64% 25.68%
Quarterly Report Q2 8-K 2013-12-31 1.05% 29.93% -2.41%
Quarterly Report Q1 8-K 2013-09-30 0.56% 107.61% 8.33%
Quarterly Report Q4 8-K 2013-06-30 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2013-03-31 0.00% 0.00% 0.00%
Quarterly Report Q2 8-K 2012-12-31 0.00% 0.00% 0.00%
Quarterly Report Q1 8-K 2012-09-30 0.00% 0.00% 0.00%